Objective:Health: - Molnupiravir: Merck's New Anti-Covid Medication is Worse Than You Thought

Last month pharmaceutical giant Merck has submitted their new drug Molnupiravir to the FDA for emergency approval 'because Covid'. Most people thought this would be an ivermectin knock-off that would get approved and get all the glory ivermectin should have been getting all along. But it's not that. It's worse. Much worse. Far from being a simple anti-viral like its predecessors, Molnupiravir works by incorporating itself into the genetic material of viruses, and then causing a huge number...